Investing Profile
Cristina Ghenoiu
Your Intro Paths to Cristina Ghenoiu
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Cristina is a member of
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Boston Consulting Group (BCG) Network
288 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
Cornell Law School Network
26 CONNECTIONS
Find Cristina Ghenoiu on
cbCurrent Investing Position
Mubadala Capital Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
2
Cristina Ghenoiu is on these Sector & Stage Rankings
Medical Devices (Seed)Pharmaceuticals (Seed)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Seed)Pharmaceuticals (Series B)Pharmaceuticals (Series A)Health & Hospital Services (Series B)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)Boston / New EnglandDiagnostics (Series B)Diagnostics (Series A)Diagnostics (Seed)Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Cristina Ghenoiu's Investments On Record (2)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Juvena Therapeutics | Series BJan 2026$34M | $75M |
Capacity Bio | Series AMar 2023$35M | $35M |
Cristina Ghenoiu's Experience
Participant In Bridge To BCG Boston Consulting Group (BCG)Present
Visiting Student Universitätsklinikum FreiburgPresent
Ph.D. Candidate in Chromosome and Cell Biology The Rockefeller UniversityPresent
Teaching Assistantship, Molecular Genetics Cornell Law SchoolPresent
Marketing Intern DocphinPresent
Postdoctoral Research Associate The Rockefeller UniversityPresent
Biotech Equity Research Associate Cowen Inc.Present
Senior Investment Professional Longitude CapitalPresent
Diligence Lead Molecular TemplatesPresent
Diligence Lead Legado WhiskeyPresent
Board Observer VaxcytePresent
Diligence Lead CuraSen Therapeutics, Inc.Present
Board Observer 89bioPresent
Board Observer HotmailPresent
SVP of R&D Ops. & New Product Planning Epirium BioPresent
Principal RA Capital ManagementPresent
Board Director HotmailPresent
Board Director Capacity BioPresent
Board Director Superluminal Medicines Inc.Present
Board Observer & Scientific Co-Founder Rivus PharmaceuticalsPresent
Partner Mubadala CapitalPresent
Cristina Ghenoiu's Education
Pearson College UWC International baccalaureate Sciences
Mount Holyoke College BA Biochemistry, Magna cum Laude and High Honors for Quantum Chemistry Thesis
The American University in Cairo Study Abroad Egyptology
Weill Cornell Graduate School of Medical Sciences Ph.D. Chromosome and Cell Biology
Weill Cornell Graduate School of Medical Sciences Ph.D. Epigenetics, Chromosome and Cell Biology
Founders who looked at Cristina Ghenoiu's profile also looked at these Scouts & Angels